Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer.

Takashi Mitamura Tianyue ZhaiKanako C HatanakaYutaka HatanakaToraji AmanoLei WangShinya TanakaHidemichi Watari

Published in: Pharmacogenomics and personalized medicine (2022)

is correlated with an excellent prognosis and can be used to establish a new strategy for treating advanced ovarian cancer.

Keyphrases